发明申请
- 专利标题： MITIGATION OF CONTRAST-INDUCED NEPHROPATHY
- 专利标题（中）： 对比诱导性肾病的缓解
-
申请号： US12611172申请日： 2009-11-03
-
公开(公告)号： US20100114064A1公开(公告)日： 2010-05-06
- 发明人: John F. Kalafut , Alan D. Hirschman , David M. Griffiths , Thomas P. Joyce , Jerry A. Stokes , Gerald W. Callan , Dennis P. Hack , Julie Gulick , Andreas R. Maihoefer , Arthur E. Uber, III
- 申请人： John F. Kalafut , Alan D. Hirschman , David M. Griffiths , Thomas P. Joyce , Jerry A. Stokes , Gerald W. Callan , Dennis P. Hack , Julie Gulick , Andreas R. Maihoefer , Arthur E. Uber, III
- 申请人地址： US PA Indianola
- 专利权人： MEDRAD, INC.
- 当前专利权人： MEDRAD, INC.
- 当前专利权人地址： US PA Indianola
- 主分类号： A61M31/00
- IPC分类号： A61M31/00 ; A61M5/14
摘要：
A system, includes a pressurizing mechanism to pressurize a fluid including a contrast enhancement agent for delivery to a patient; and a control system in operative connection with the pressurizing mechanism. The control system includes a system to adjust control of fluid injection based upon a measurement of renal function of the patient.
公开/授权文献
- US09421330B2 Mitigation of contrast-induced nephropathy 公开/授权日：2016-08-23